Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Misonix signs distribution agreement with MD International
The agreement provides MD International with the right to sell in Latin America and includes minimum purchase requirements. To date, four SonaStar systems have been shipped to Chile
The agreement provides MD International with the right to sell in Latin America and includes minimum purchase requirements. To date, four SonaStar systems have been shipped to Chile
The Albuquerque business provides cGMP glass vial filling and lyophilization services for injectable drugs and biologics that are either approved for commercial marketing or in clinical development. Oso
Most recently, Mr Moyes served as vice president of finance and CFO at Myriad Genetics, a publicly traded molecular diagnostics and therapeutic development company. Prior to that, Mr
The randomized Phase II study with Telintra tablets in myelodysplastic syndrome (MDS) is expected to enroll 86 patients, with an anticipated 20 sites participating in the study. Two
The study demonstrated that 94% of the men had their testosterone levels restored and maintained to within normal levels; further, 92% of these men expressed satisfaction with their
Kai’s randomized, double-blind, placebo-controlled, rising single-dose study will evaluate the safety, tolerability and pharmacokinetics of KAI-1678 in healthy males. The study will enroll five cohorts and is expected
The Phase II clinical trial is a randomized, open-label, multi-center trial evaluating GI-5005 in combination with full duration standard of care, versus standard of care alone in patients
The Phase I randomized, double-blind, vehicle-controlled and parallel-assigned study of OMS201 evaluates the systemic absorption and safety of OMS201 in patients receiving primary treatment by endoscopic removal of
Mary Dillahunty, vice president of intellectual property at Oncolytics, said: “This patent provides the company with additional patent protection for reovirus compositions in the US.”
Under the collaboration, FivePrime will screen its comprehensive protein library in both cell-based assays and primary in vivo screens directed toward finding potential therapeutic protein products and antibody